As of 2025-10-21, the Relative Valuation of Foghorn Therapeutics Inc. (FHTX) is (3.40) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.04 USD, the upside of Foghorn Therapeutics Inc. based on Relative Valuation is -184.2%.
The range of the Relative Valuation is (2.72) - (4.08) USD.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | 2.0x - 3.1x | 2.6x |
| Fair Price | (2.72) - (4.08) | (3.40) |
| Upside | -167.3% - -201.0% | -184.2% |
| Date | P/E |